Lee H. Harrison

Active 1983–2026

198
Papers
37,971
Citations
101
h-index
178
i10-index

Citations

Citations per year for Lee H. Harrison1984: 1 citations1985: 2 citations1986: 2 citations1987: 3 citations1988: 6 citations1989: 7 citations1990: 5 citations1991: 6 citations1992: 9 citations1993: 3 citations1994: 1 citations1995: 1 citations1996: 9 citations1997: 4 citations1998: 16 citations1999: 44 citations2000: 62 citations2001: 94 citations2002: 133 citations2003: 147 citations2004: 199 citations2005: 255 citations2006: 327 citations2007: 328 citations2008: 387 citations2009: 369 citations2010: 396 citations2011: 340 citations2012: 285 citations2013: 278 citations2014: 264 citations2015: 253 citations2016: 253 citations2017: 245 citations2018: 213 citations2019: 836 citations2020: 749 citations2021: 681 citations2022: 570 citations2023: 429 citations2024: 766 citations2025: 342 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,403 citing papers, 29.6% of this breakdownUnited Kingdom: 1,005 citing papers, 8.7% of this breakdownChina: 425 citing papers, 3.7% of this breakdownCanada: 387 citing papers, 3.4% of this breakdownFrance: 382 citing papers, 3.3% of this breakdownAustralia: 379 citing papers, 3.3% of this breakdownGermany: 332 citing papers, 2.9% of this breakdownSpain: 328 citing papers, 2.9% of this breakdownNetherlands: 328 citing papers, 2.9% of this breakdownItaly: 298 citing papers, 2.6% of this breakdownIndia: 247 citing papers, 2.1% of this breakdownBrazil: 214 citing papers, 1.9% of this breakdown
0%29.6%Other 32.7%

Fields

  • Medicine68.6%
  • Immunology and Microbiology14.4%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Agricultural and Biological Sciences3.6%
  • Environmental Science1.1%
  • Health Professions0.7%
  • Other2.9%

Topics

  • Pneumonia and Respiratory Infections10.3%
  • Bacterial Infections and Vaccines5.4%
  • Respiratory viral infections research5.1%
  • Antifungal resistance and susceptibility4.3%
  • Streptococcal Infections and Treatments4%
  • Antimicrobial Resistance in Staphylococcus3.8%
  • Other67.1%

Coauthors

All papers

Open in search
  1. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015

    Authors: , , , , , , , , , , , , , , , , , , - JAMA Pediatrics 2019 cited by 397

  2. Whole-Genome Sequencing Surveillance and Machine Learning of the Electronic Health Record for Enhanced Healthcare Outbreak Detection

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 129

  3. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2015 cited by 730

  4. Multilocus Sequence Typing as a Replacement for Serotyping in Salmonella enterica

    Authors: , , , , , , , , , , , , , - PLoS Pathogens 2012 cited by 708

  5. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005–2012

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 413

  6. Systematic detection of horizontal gene transfer across genera among multidrug-resistant bacteria in a single hospital

    Authors: , , , , , , , , , - eLife 2020 cited by 162

  7. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

    Authors: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2009 cited by 1,327

  8. Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016

    Authors: , , , , , , , , , , , , - MMWR Surveillance Summaries 2019 cited by 191

  9. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

    Authors: , , , , , , , , , , , , - Journal of Infection 2020 cited by 262

  10. Burden of Candidemia in the United States, 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 161

  11. Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016

    Authors: , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2019 cited by 211

  12. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 cited by 197

  13. Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 2,243

  14. Bacterial Meningitis in the United States, 1998–2007

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 953

  15. Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015

    Authors: , , , - MMWR Morbidity and Mortality Weekly Report 2016 cited by 146

  16. The surge of mpox in Africa: a call for action

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2024 cited by 50

  17. Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis

    Authors: , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,035

  18. Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance

    Authors: , , , , , , , - PLoS ONE 2015 cited by 304

  19. Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance

    Authors: , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2014 cited by 230

  20. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine

    Authors: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 148

  21. The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 138

  22. Evolution of Outbreak-Causing Carbapenem-Resistant Klebsiella pneumoniae ST258 at a Tertiary Care Hospital over 8 Years

    Authors: , , , , , , , , , , , , , - mBio 2019 cited by 120

  23. Methicillin-ResistantStaphylococcus aureusDisease in Three Communities

    Authors: , , , , , , , , , - New England Journal of Medicine 2005 cited by 1,501

  24. Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

    Authors: , , , , , , , , , , - Journal of Clinical Microbiology 2012 cited by 294